{
    "clinical_study": {
        "@rank": "11472", 
        "acronym": "COSTUM", 
        "arm_group": {
            "arm_group_label": "echography", 
            "arm_group_type": "Experimental", 
            "description": "Fast Cerebral Pulsatility Imaging"
        }, 
        "brief_summary": {
            "textblock": "The new technical of ultrasonic exploration of this project purpose to validate the\n      measurement of cerebral pulsatility by a new way called \"Fast Cerebral Pulsatility Imaging\"\n      (FCPI).This will somehow determine the natural history of cerebral pulsatility during\n      development adult to old age"
        }, 
        "brief_title": "Ultrasonic Explorations of Cerebral Tissue Motions - Influence of Aging", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Aging", 
            "Cerebral Pulsatility"
        ], 
        "detailed_description": {
            "textblock": "Main objective\n\n      Phase 1:\n\n      -Study the in-vivo development of ultrasonic method in terms of quality of the acquisitions\n      and intra-operator reproducibility.\n\n      Study the ease of positioning in relation to MRI and fusion of MRI and FCPI data via the\n      neuro-navigation system\n\n      Phase 2:\n\n      -Study the variability of cerebral pulsatility of measured by \"Fast Cerebral Pulsatility\n      Imaging\" or FCPI with age.\n\n      Secondary objectives\n\n        -  Compare the results of displacements cartography's and vascular cartography obtained by\n           MRI (especially by Arteriel Spin Labelling = ASL)\n\n        -  Compare results of FCPI with results of cognitive tests of aging separating fluid\n           functions (prefrontal) and functions called crystallized; and study the residual effect\n           of age on cognitive tasks and speed of cognitive processing after taking into account\n           the effect of the cerebral pulsatility\n\n        -  Compare results of FCPI with electrophysiological measures (PE EEG) describing the\n           attentional control\n\n        -  Perform an exploratory analysis to highlight the propagating part of the brain\n           displacement maps"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient at least 18 years old\n\n          -  Informed consent form signed\n\n          -  Person affiliated to a medical insurance\n\n          -  Male or female\n\n          -  No smoking the day of the inclusion\n\n          -  Right handed: Edinburgh test \u22650.8 (subjects of phase 2)\n\n          -  MMS score \u2265 27 and 5 words score = 10 (subjects of phase 2)\n\n          -  Socio-educational level greater than or equal to 8 years of school (subjects of phase\n             2)\n\n        Exclusion Criteria:\n\n          -  Pregnant women, lactating women or women without reliable contraception\n\n          -  Contraindications to IRM for patients with: ocular metallic foreign object; any\n             electronic medical device implanted by irremovable way (pacemakers, neuro-stimulator,\n             cochlear implants ...); metallic heart valve, old heart valves are specially an\n             absolute contraindication because of risk of dysfunction; vascular clips implanted\n             formerly on brain aneurysm\n\n          -  Acute medico-surgical condition dating from less than 3 months\n\n          -  Neurological and neuro-surgical pathology such as: toxic, infectious or inflammatory\n             encephalopathy, epilepsy, intracranial arteriovenous malformation known, intracranial\n             tumor or hydrocephalus known, operated or no, history of ischemic or hemorrhagic\n             stroke, transient or not\n\n          -  Treatments or pathology that could influence the results of the research: heart\n             failure (dyspnea with stage III or IV NYHA) or non-sinus cardiac rhythm, use of\n             central analgesics or psychotropic drugs\n\n          -  Psychiatrics disorders of axe 1 of DSM IV, based on MINI (subjects of phase 2)\n\n          -  Major subject with a legal protection measure\n\n          -  Subject to exclusion period of any other biomedical research"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "53", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 19, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01737606", 
            "org_study_id": "PHAO 2012 - FP / COSTUM"
        }, 
        "intervention": {
            "arm_group_label": "echography", 
            "description": "Cerebral ultrasonic exploration using with neuro-navigation system : 4 acquisitions on 12 or 6 section planes", 
            "intervention_name": "Fast Cerebral Pulsatility Imaging", 
            "intervention_type": "Device", 
            "other_name": "FCPI"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cerebral pulsatility", 
            "Fast Cerebral Pulsatility Imaging or FCPI", 
            "MRI", 
            "Arteriel Spin Labelling", 
            "Cognitive tasks", 
            "Aging"
        ], 
        "lastchanged_date": "September 27, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tours", 
                    "country": "France", 
                    "zip": "37044"
                }, 
                "name": "University Hospital of Tours"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Ultrasonic Explorations of Cerebral Tissue Motions - Influence of Aging", 
        "overall_official": {
            "affiliation": "University Hospital of Tours", 
            "last_name": "Fr\u00e9d\u00e9ric PATAT, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Time of implementation of procedure\nQualitative identification of anatomical landmarks of positioning in space of the US probe using neuro-navigation system; if available quantitative measure: x,y,z or distance to a region of interest(ROI)\nPerfusion values: Cerebral Blood Flow of Willis' Circle in MRI\nSignal to noise ratio\nAmplitude (max displacement value), location (x,y,z of location of this max or distance to a ROI) of FCPI\nBandwidth of metrology of FCPI\nPossibility to indentify the propagation phenomenon underlying to displacements (speed and attenuation of the shear wave)", 
                "measure": "Phase 1 : to validate the technical procedure, we will appreciate several parameters", 
                "safety_issue": "No", 
                "time_frame": "up to 8 days after consent"
            }, 
            {
                "description": "We hypothesize that the variables describing the FCPI will decrease with age. The primary outcome measures will be the maximum amplitude and the average amplitude of cerebral movements measured in \u00b5m in planes chosen previously (for example plan of Circle of Willis and a plane including the dorsolateral area of prefrontal cortex).", 
                "measure": "Phase 2 : the primary outcome measures will be the maximum amplitude and the average amplitude of cerebral movements", 
                "safety_issue": "No", 
                "time_frame": "up to 8 days after consent"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01737606"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Maps of cerebral displacement obtained by ultrasounds (amplitudes in \u00b5m and location in mm) and tissular perfusion maps obtained by Arterial Spin Labelling (Cerebral Blood Flow in \u00b5L.g-1.mn-1)", 
                "measure": "Phase 2 : Maps of cerebral displacementand tissular perfusion maps", 
                "safety_issue": "No", 
                "time_frame": "up to 8 days after consent"
            }, 
            {
                "description": "Measures of FCPI on the regions of interest: amplitude (maximum displacement values, \u00b5m) and location x, y, z, of the location of this maximum in mm, or distance to a region of interest) on the hand and cognitive tests on the other hand expressed with a numerical score for each test.", 
                "measure": "Phase 2 : Measures of FCPI on the regions of interest and cognitive tests", 
                "safety_issue": "No", 
                "time_frame": "up to 8 days after consent"
            }, 
            {
                "description": "Measures of FCPI on the regions of interest: amplitude (maximum displacement values, \u00b5m) and location x, y, z, of the location of this maximum in mm, or distance to a region of interest) on the hand and measures of PE EEG on the other hand expressed in terms of amplitude (\u00b5V), latency (ms), duration (ms)", 
                "measure": "Phase 2 : Measures of FCPI on the regions of interestand measures of PE EEG", 
                "safety_issue": "No", 
                "time_frame": "up to 8 days after consent"
            }, 
            {
                "description": "The signal to noise ratio of maps speed (m/s) and attenuation \u03b1 (cm-1) of the shear wave obtained by mathematical processing of displacement maps", 
                "measure": "Phase 2 : The signal to noise ratio", 
                "safety_issue": "No", 
                "time_frame": "up to 8 days after consent"
            }
        ], 
        "source": "University Hospital, Tours", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Tours", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}